CAMBRIDGE, Mass., July 26, 2021 /PRNewswire/ -- Akebia
Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company
with the purpose to better the lives of people impacted by kidney
disease, today announced plans to release its financial results for
the second quarter ended June 30,
2021, on Thursday, August 5,
2021 before the opening of the financial markets.
Akebia will host a conference call at 9:00 a.m. Eastern Time on Thursday, August 5, to
discuss its second quarter financial results and recent business
highlights. To listen to the conference call, please dial (877)
458-0977 (domestic) or (484) 653-6724 (international) using
conference ID number 5529396. The call will also be webcast
LIVE and can be accessed via the Investors section of the Company's
website at http://ir.akebia.com.
A replay of the conference call will be available two hours
after the completion of the call through August 11, 2021. To
access the replay, dial (855) 859-2056 (domestic) or (404) 537-3406
(international) and reference conference ID number 5529396. An
online archive of the conference call can be accessed via the
Investors section of the Company's website
at http://ir.akebia.com.
About Akebia Therapeutics
Akebia Therapeutics,
Inc. is a fully integrated biopharmaceutical company with the
purpose to better the lives of people impacted by kidney disease.
The Company was founded in 2007 and is headquartered in
Cambridge, Massachusetts. For more
information, please visit our website at https://akebia.com/ which
does not form a part of this release.
Investor Contact
Kristen K. Sheppard, Esq.
ir@akebia.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-report-second-quarter-2021-financial-results-and-discuss-recent-business-highlights-301340605.html
SOURCE Akebia Therapeutics